CS logo
small CS logo
Cancer Research UK and University College London Cancer Trials Centre

London, England, United Kingdom

About Cancer Research UK and University College London Cancer Trials Centre


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
AstraZeneca
2
Cancer Research UK
2
University College, London
2
EBMT Solid Tumors Working Party
1
European Organisation for Research and Treatment of Cancer - EORTC
1
Karus Therapeutics Limited
1
University College London (UCL) Cancer Institute
1
University of Glasgow
1
Total Rows: 8

Clinical Trials at Cancer Research UK and University College London Cancer Trials Centre


During the past decade, Cancer Research UK and University College London Cancer Trials Centre conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails202000.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery
1998-09-01
2007-09-01
Completed
Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer
2001-03-01
2007-08-01
Completed
600
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
2002-05-01
Terminated
119
Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain
2003-04-01
2011-07-01
Completed
580
Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma
2005-10-01
2017-01-01
Completed
614
Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer
2007-12-01
2015-01-01
Completed
78
Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
2006-03-01
2011-07-01
Completed
62
Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery
2010-06-01
2012-12-01
Completed
130

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Cancer Research UK and University College London Cancer Trials Centre" #1 sponsor was "AstraZeneca" with 2 trials, followed by "Cancer Research UK" with 2 trials sponsored, "University College, London" with 2 trials sponsored, "EBMT Solid Tumors Working Party" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Research UK and University College London Cancer Trials Centre" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Myriad Genetic Laboratories, Inc." with 2 trials as a collaborator, "Arbeitsgruppe Lebermetastasen und Tumoren" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAstraZeneca: 2AstraZeneca: 2Cancer Research UK: 2Cancer Research UK: 2University College, London: 2University College, London: 2EBMT Solid TumorsWorking Party: 1EBMT Solid TumorsWorking Party: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1Karus Therapeutics Limited: 1Karus Therapeutics Limited: 1University CollegeLondon (UCL) CancerInstitute: 1University CollegeLondon (UCL) CancerInstitute: 1University of Glasgow: 1University of Glasgow: 1

Created with Highcharts 11.1.0Top CollaboratorsMerck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2Myriad GeneticLaboratories, Inc.: 2Myriad GeneticLaboratories, Inc.: 2ArbeitsgruppeLebermetastasen undTumoren: 1ArbeitsgruppeLebermetastasen undTumoren: 1European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1GOG Foundation: 1GOG Foundation: 1Institute of CancerResearch, UnitedKingdom: 1Institute of CancerResearch, UnitedKingdom: 1University College, London: 1University College, London: 1

Clinical Trials Conditions at Cancer Research UK and University College London Cancer Trials Centre


According to Clinical.Site data, the most researched conditions in "Cancer Research UK and University College London Cancer Trials Centre" are "Lymphoma" (2 trials), "Metastatic Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Advanced Ovarian Cancer" (1 trials) and "Anal Cancer" (1 trials). Many other conditions were trialed in "Cancer Research UK and University College London Cancer Trials Centre" in a lesser frequency.

Clinical Trials Intervention Types at Cancer Research UK and University College London Cancer Trials Centre


Most popular intervention types in "Cancer Research UK and University College London Cancer Trials Centre" are "Drug" (10 trials), "Biological" (3 trials), "Procedure" (3 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Olaparib 300mg tablets" (2 trials), "carboplatin" (2 trials), "cyclophosphamide" (2 trials), "fluorouracil" (2 trials) and "paclitaxel" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Cancer Research UK and University College London Cancer Trials Centre


The vast majority of trials in "Cancer Research UK and University College London Cancer Trials Centre" are 7 trials for "All" genders and 4 trials for "Female" genders.

Clinical Trials Status at Cancer Research UK and University College London Cancer Trials Centre


Currently, there are NaN active trials in "Cancer Research UK and University College London Cancer Trials Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Cancer Research UK and University College London Cancer Trials Centre, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Cancer Research UK and University College London Cancer Trials Centre, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 5Phase 2: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Active, not recruiting: 2Active, not recruiting: 2Terminated: 1Terminated: 1Withdrawn: 1Withdrawn: 1